Izumi Kimura

8.2k total citations · 1 hit paper
18 papers, 697 citations indexed

About

Izumi Kimura is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, Izumi Kimura has authored 18 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Virology and 5 papers in Infectious Diseases. Recurrent topics in Izumi Kimura's work include HIV Research and Treatment (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Herpesvirus Infections and Treatments (4 papers). Izumi Kimura is often cited by papers focused on HIV Research and Treatment (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Herpesvirus Infections and Treatments (4 papers). Izumi Kimura collaborates with scholars based in Japan, United Kingdom and Germany. Izumi Kimura's co-authors include Kei Sato, Yoriyuki Konno, Yoshio Koyanagi, Keiya Uriu, So Nakagawa, Daniel Sauter, Robert J. Gifford, Masaya Fukushi, Takashi Irie and Tatsuro Kaminaga and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and Science Advances.

In The Last Decade

Izumi Kimura

18 papers receiving 681 citations

Hit Papers

SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose ... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Izumi Kimura Japan 9 410 182 146 89 87 18 697
Camille R. Simoneau United States 8 272 0.7× 259 1.4× 183 1.3× 49 0.6× 77 0.9× 11 679
Philipp Schommers Germany 17 486 1.2× 147 0.8× 209 1.4× 17 0.2× 130 1.5× 31 872
Christopher E. Yi United States 7 329 0.8× 50 0.3× 157 1.1× 38 0.4× 67 0.8× 10 489
Tanya A. Miura United States 15 314 0.8× 164 0.9× 194 1.3× 18 0.2× 206 2.4× 38 672
Daniel Galbraith United Kingdom 14 160 0.4× 112 0.6× 89 0.6× 195 2.2× 89 1.0× 19 725
Susan E. Burkett United States 8 343 0.8× 206 1.1× 117 0.8× 24 0.3× 122 1.4× 8 789
Fatma Berri France 11 264 0.6× 162 0.9× 102 0.7× 53 0.6× 213 2.4× 19 580
Jianqi Lian China 17 298 0.7× 320 1.8× 153 1.0× 14 0.2× 342 3.9× 58 867
Katharina Esser‐Nobis Germany 12 258 0.6× 342 1.9× 298 2.0× 40 0.4× 334 3.8× 17 862
Nan Su China 12 195 0.5× 106 0.6× 49 0.3× 15 0.2× 98 1.1× 38 544

Countries citing papers authored by Izumi Kimura

Since Specialization
Citations

This map shows the geographic impact of Izumi Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izumi Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izumi Kimura more than expected).

Fields of papers citing papers by Izumi Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izumi Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izumi Kimura. The network helps show where Izumi Kimura may publish in the future.

Co-authorship network of co-authors of Izumi Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Izumi Kimura. A scholar is included among the top collaborators of Izumi Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izumi Kimura. Izumi Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Watanabe, Yukio, Izumi Kimura, Rina Hashimoto, et al.. (2023). Virological characterization of the 2022 outbreak‐causing monkeypox virus using human keratinocytes and colon organoids. Journal of Medical Virology. 95(6). e28827–e28827. 15 indexed citations
2.
Fujita, Shigeru, Yusuke Kosugi, Izumi Kimura, Daichi Yamasoba, & Kei Sato. (2022). Structural Insight into the Resistance of the SARS-CoV-2 Omicron BA.4 and BA.5 Variants to Cilgavimab. Viruses. 14(12). 2677–2677. 1 indexed citations
3.
Kimura, Izumi, Yoriyuki Konno, Keiya Uriu, et al.. (2021). Sarbecovirus ORF6 proteins hamper induction of interferon signaling. Cell Reports. 34(13). 108916–108916. 54 indexed citations
4.
Ferreira, Isabella A.T.M., Steven A. Kemp, Rawlings Datir, et al.. (2021). SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion. The Journal of Infectious Diseases. 224(6). 989–994. 72 indexed citations
5.
Kosugi, Yusuke, Keiya Uriu, Narumi Suzuki, et al.. (2021). Comprehensive Investigation on the Interplay between Feline APOBEC3Z3 Proteins and Feline Immunodeficiency Virus Vif Proteins. Journal of Virology. 95(13). e0017821–e0017821. 2 indexed citations
6.
Ito, Jumpei, Izumi Kimura, Alexandre Coudray, et al.. (2020). Endogenous retroviruses drive KRAB zinc-finger protein family expression for tumor suppression. Science Advances. 6(43). 41 indexed citations
7.
Konno, Yoriyuki, Izumi Kimura, Keiya Uriu, et al.. (2020). SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant. Cell Reports. 32(12). 108185–108185. 312 indexed citations breakdown →
8.
Kimura, Izumi, Yoriyuki Konno, Daniel Sauter, So Nakagawa, & Kei Sato. (2020). <i>Sarbecovirus</i>&nbsp;ORF6 Proteins Hamper the Induction of Interferon Signaling by Blocking mRNA Nuclear Export. SSRN Electronic Journal. 1 indexed citations
9.
Kimura, Izumi, Shumpei Nagaoka, Yoriyuki Konno, et al.. (2018). Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control. Frontiers in Immunology. 8. 1823–1823. 63 indexed citations
10.
Konno, Yoriyuki, Shumpei Nagaoka, Izumi Kimura, et al.. (2018). New World feline APOBEC3 potently controls inter-genus lentiviral transmission. Retrovirology. 15(1). 31–31. 6 indexed citations
11.
Konno, Yoriyuki, Shumpei Nagaoka, Izumi Kimura, et al.. (2018). A naturally occurring feline APOBEC3 variant that loses anti-lentiviral activity by lacking two amino acid residues. Journal of General Virology. 99(5). 704–709. 4 indexed citations
12.
Sato, Kei, Naoko Misawa, Junko S. Takeuchi, et al.. (2017). Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model. Journal of Virology. 92(4). 19 indexed citations
13.
Kaminaga, Tatsuro, et al.. (2003). Role of magnetic resonance imaging for evaluation of tumors in the cardiac region. European Radiology. 13(S06). L1–L10. 84 indexed citations
14.
Kimura, Izumi, et al.. (1996). A Clinical Statistical Study on Oral Mucosal Lesions. 2(1). 69–75. 2 indexed citations
15.
Aikawa, Atsushi, Izumi Kimura, K Arai, et al.. (1989). Comparison of lymphocyte subsets of peripheral blood and grafts in renal transplant recipients.. PubMed. 21(1 Pt 2). 1859–60. 2 indexed citations
17.
Kimura, Izumi. (1974). Nucleic acid metabolism in sea urchin embryos and its alteration after X-irradiation. Experimental Cell Research. 89(2). 327–335. 5 indexed citations
18.
Kimura, Izumi & Koichi Suzuki. (1969). The antigenicity of human hemoglobins. Annals of Hematology. 19(3). 129–138. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026